CorMedix Inc.
DE ˙ DB ˙ US21900C3088
6,91 € ↓ -0,13 (-1,79%)
2026-06-03
AKTIENPREIS
SecurityDE:19KA / CorMedix Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership4,567,897 shares
Ownership 7.50%
BlackRock, Inc. ownership in 19KA / CorMedix Inc.

2025-02-05 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,567,897 shares of CorMedix Inc. (DE:19KA). This represents 7.5 percent ownership of the company. In their previous filing dated 2024-01-29 , BlackRock, Inc. had reported owning 3,507,695 shares, indicating an increase of 30.23 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2025-02-05 2025-02-05 13G/A 3,507,695 4,567,897 30.23 7.50 17.19
2024-01-29 2024-01-29 13G 637,778 3,507,695 449.99 6.40 300.00
2022-07-08 2022-07-08 13G 2,500,721 637,778 -74.50 1.60 -75.76
2022-02-03 2022-02-03 13G/A 1,995,193 2,500,721 25.34 6.60 6.45
2021-01-29 2021-01-29 13G/A 1,712,901 1,995,193 16.48 6.20 -7.46
2020-02-07 2020-02-07 13G 1,745,102 1,712,901 -1.85 6.70 36.73
2016-03-10 2016-03-10 13G/A 1,808,474 1,745,102 -3.50 4.90 -3.92
2016-01-28 2016-01-28 13G 1,808,474 5.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CORMEDIX COM 21900C308 5,967,575 191,147 3.31 40,520 -39.69 0.0007
2026-02-12 2025-12-31 13F CORMEDIX COM 21900C308 5,776,428 88,125 1.55 67,180 1.55 0.0011
2025-11-12 2025-09-30 13F CORMEDIX COM 21900C308 5,688,303 328,474 6.13 66,155 0.18 0.0012
2025-08-12 2025-06-30 13F CORMEDIX COM 21900C308 5,359,829 633,854 13.41 66,033 126.82 0.0013
2025-05-02 2025-03-31 13F CORMEDIX COM 21900C308 4,725,975 158,078 3.46 29,112 -21.32 0.0006
2025-02-07 2024-12-31 13F CORMEDIX COM 21900C308 4,567,897 911,603 24.93 37,000 25.24 0.0007
2024-11-13 2024-09-30 13F CORMEDIX COM 21900C308 3,656,294 102,820 2.89 29,543 92.01 0.0006
2024-08-13 2024-06-30 13F CORMEDIX COM 21900C308 3,553,474 66,480 1.91 15,387 4.07 0.0003
2024-05-10 2024-03-31 13F CORMEDIX COM 21900C308 3,486,994 -20,701 -0.59 14,785 12.10 0.0003
2024-02-13 2023-12-31 13F CORMEDIX COM 21900C308 3,507,695 349,037 11.05 13,189 12.84 0.0003
2023-11-13 2023-09-30 13F CORMEDIX COM 21900C308 3,158,658 433,961 15.93 11,687 8.18 0.0003
2023-08-11 2023-06-30 13F CORMEDIX COM 21900C308 2,724,697 2,081,542 323.65 10,803 305.82 0.0003
2023-05-12 2023-03-31 13F CORMEDIX COM 21900C308 643,155 2,337 0.36 2,663 -1.55 0.0001
2023-02-13 2022-12-31 13F CORMEDIX COM 21900C308 640,818 7,649 1.21 2,704 50.98 0.0001
2022-11-14 2022-09-30 13F CORMEDIX COM 21900C308 633,169 -4,609 -0.72 1,791 -30.15 0.0001
2022-08-12 2022-06-30 13F CORMEDIX COM 21900C308 637,778 -1,785,439 -73.68 2,564 -80.69 0.0001
2022-05-12 2022-03-31 13F CORMEDIX COM 21900C308 2,423,217 -77,504 -3.10 13,279 16.70 0.0004
2022-02-10 2021-12-31 13F CORMEDIX COM 21900C308 2,500,721 -5,673 -0.23 11,379 -2.37 0.0003
2021-11-09 2021-09-30 13F CORMEDIX COM 21900C308 2,506,394 13,380 0.54 11,655 -31.85 0.0003
2021-08-11 2021-06-30 13F CORMEDIX COM 21900C308 2,493,014 239,720 10.64 17,101 -24.03 0.0005
2021-05-07 2021-03-31 13F CORMEDIX COM 21900C308 2,253,294 258,101 12.94 22,510 51.85 0.0007
2021-02-05 2020-12-31 13F CORMEDIX COM 21900C308 1,995,193 88,855 4.66 14,824 28.96 0.0005
2020-11-06 2020-09-30 13F CORMEDIX COM 21900C308 1,906,338 127,448 7.16 11,495 2.57 0.0004
2020-08-14 2020-06-30 13F CORMEDIX COM 21900C308 1,778,890 67,219 3.93 11,207 82.41 0.0004
2020-05-01 2020-03-31 13F CORMEDIX COM 21900C308 1,711,671 -1,230 -0.07 6,144 -50.73 0.0003
2020-02-13 2019-12-31 13F CORMEDIX COM 21900C308 1,712,901 107,187 6.68 12,470 21.72 0.0005
2019-11-08 2019-09-30 13F CORMEDIX COM 21900C308 1,605,714 208,299 14.91 10,245 -18.27 0.0004
2019-08-22 2019-06-30 13F/A-1 CORMEDIX COM 21900C308 1,397,415 975,813 231.45 12,535 214.63 0.0005
2019-08-13 2019-06-30 13F CORMEDIX COM 21900C308 1,397,415 975,813 12,535
2019-05-09 2019-03-31 13F CORMEDIX COM 21900C308 421,602 -2,235,070 -84.13 3,984 16.25 0.0002
2019-02-08 2018-12-31 13F CORMEDIX COM 21900C100 2,656,672 2,096,663 374.40 3,427 531.12 0.0002
2018-11-09 2018-09-30 13F CORMEDIX COM 21900C100 560,009 628 0.11 543 311.36 0.0000
2018-08-09 2018-06-30 13F CORMEDIX COM 21900C100 559,381 1,424 0.26 132 30.69 0.0000
2018-05-09 2018-03-31 13F CORMEDIX COM 21900C100 557,957 -5,818 -1.03 101 -64.31 0.0000
2018-02-09 2017-12-31 13F CORMEDIX COM 21900C100 563,775 944 0.17 283 -3.41 0.0000
2017-11-14 2017-09-30 13F CORMEDIX COM 21900C100 562,831 1,596 0.28 293 22.08 0.0000
2017-08-10 2017-06-30 13F CORMEDIX COM 21900C100 561,235 -164,171 -22.63 240 -79.70 0.0000
2017-05-12 2017-03-31 13F CORMEDIX COM 21900C100 725,406 725,406 29.25 1,182 392.50 0.0001
2016-08-10 2016-06-30 13F CORMEDIX COM 21900C100 0 -497 -100.00 0 -100.00
2016-05-10 2016-03-31 13F CORMEDIX COM 21900C100 497 497 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.